A detailed history of Four Thought Financial, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Four Thought Financial, LLC holds 138 shares of SAGE stock, worth $756. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138
Previous 138 -0.0%
Holding current value
$756
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022

SELL
$37.06 - $47.11 $2,557 - $3,250
-69 Reduced 33.33%
138 $6,000
Q3 2021

Nov 12, 2021

SELL
$40.26 - $57.37 $1,368 - $1,950
-34 Reduced 14.11%
207 $9,000
Q4 2020

Nov 12, 2021

BUY
$58.41 - $89.06 $14,076 - $21,463
241 New
241 $20,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.